GlucoTrack's $11.6M Deal Yields Only $4.5M Cash, Dilution Looms
Markets Daniel Marsh

GlucoTrack's $11.6M Deal Yields Only $4.5M Cash, Dilution Looms

GlucoTrack's $11.6M financing brings only $4.5M new cash, with the rest from converted debt and discount. Shares fell 21% on dilution concerns.

GCTK
SharonAI Leadership Shift: COO Transition Preserves Founder's Equity Stake
Analysis Daniel Marsh

SharonAI Leadership Shift: COO Transition Preserves Founder's Equity Stake

SharonAI disclosed leadership changes, with co-founder Leece keeping 151,219 RSUs as Burns becomes COO. Contract runs to 2027, stock up 5%.

Netflix Pulls Plug on 'Ransom Canyon' as Audience Slips
Analysis Daniel Marsh

Netflix Pulls Plug on 'Ransom Canyon' as Audience Slips

Netflix has canceled 'Ransom Canyon' after two seasons, following a 41% drop in three-week viewership. The move underscores the streamer's focus on content ROI.

NFLX
Belden's Ruckus Buy: Margin Boost Meets $1.8B Debt Burden
Analysis Daniel Marsh

Belden's Ruckus Buy: Margin Boost Meets $1.8B Debt Burden

Belden's Ruckus acquisition boosts margins but adds $1.8B debt, cutting net income. BDC stock faces deleveraging test.

BDC
T3 Defense Bridges to Next Funding with $3M Loan
Analysis Daniel Marsh

T3 Defense Bridges to Next Funding with $3M Loan

T3 Defense has taken a $3 million bridge loan to fund operations until its planned $10 million preferred stock sale closes. The loan matures December 8 or earlier if financing is secured.

Volato's AI Merger Dilutes SOAR Shareholders to 5% Stake
Analysis Daniel Marsh

Volato's AI Merger Dilutes SOAR Shareholders to 5% Stake

Volato Group's merger with Alignment Engine leaves SOAR shareholders with a 5% stake, while a $7.5M note complicates valuation.

SOAR
Fly-E Appoints New CEO Amid Unresolved Executive Transition Questions
Analysis Daniel Marsh

Fly-E Appoints New CEO Amid Unresolved Executive Transition Questions

Fly-E Group appointed Qiang Chen as CEO following Lisa Fan's sudden resignation, but filings conflict on who held top roles. Stock dropped 17% before the news.

FLYE
Acadia Pharma Governance Overhaul Approved, No Cash for Shareholders
Regulation James Calloway

Acadia Pharma Governance Overhaul Approved, No Cash for Shareholders

Acadia Pharmaceuticals' derivative settlement brings four years of governance reforms, not cash payouts. A federal court will consider final approval in January 2027.

ACAD
DeFi Development Expands CHAD Preferred ATM to $300M for Solana Treasury
Crypto Sarah Chen

DeFi Development Expands CHAD Preferred ATM to $300M for Solana Treasury

DeFi Development Corp. has launched an at-the-market program for 30 million CHAD preferred shares, potentially raising $300M to fund Solana (SOL) acquisitions and strategic initiatives.

DFDV
Daily Journal Authorizes Share Repurchase, Revises Voting Structure
Markets Daniel Marsh

Daily Journal Authorizes Share Repurchase, Revises Voting Structure

Daily Journal Corp. authorizes a 2.5% share buyback and ends cumulative voting, replacing it with proxy access and other governance changes.

DJCO
Coty to Pay Ex-CFO $900K+ Annually Through 2027 in Transition Deal
Analysis Daniel Marsh

Coty to Pay Ex-CFO $900K+ Annually Through 2027 in Transition Deal

Coty will keep paying former CFO Laurent Mercier €825,000 annually through June 2027, plus a €290,000 bonus, even as he steps back from active duties in November.

COTY
Sandisk's Credit Line: A Strategic Hedge, Not a Cash Crunch
Analysis Daniel Marsh

Sandisk's Credit Line: A Strategic Hedge, Not a Cash Crunch

Sandisk's new $1.5B revolver is a cost-effective insurance policy, not a sign of distress. The company remains debt-free with ample cash.

SNDK